Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.54 EUR
Change Today -0.049 / -1.36%
Volume 3.0K
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:44 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John A. Scarlett M.D.

Chief Executive Officer, President and Director, Geron Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 5 different industries.

See Board Relationships
63$6,071,003
As of Fiscal Year 2014

Background*

Dr. John A. Scarlett, M.D., has been the Chief Executive Officer of Geron Corporation since September 2011 and has also been its President since January 5, 2012. Dr. Scarlett served as Chief Executive Officer and President of Onyx Therapeutics, Inc. since February 2009. He Co-Founded Ipsen Biopharmaceuticals, Inc. (Formerly Tercica Inc) in 2002 and served as its Chief Executive Officer since February 2002. Dr. Scarlett has been Chief Executive Officer and President of ...

Read Full Background

Corporate Headquarters*

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-473-7700
Fax: 650-473-7750

Board Members Memberships*

Former Chief Executive Officer, President and Director
2002-N/A
Former Chief Executive Officer
2011-Present
Chief Executive Officer, President and Director
2015-Present
Director

Education*

BA
Earlham College
MD
University Of Chicago - Pritzker School Of Medicine

Other Affiliations*

Annual Compensation*

Salary$586,500
Bonus$70,380
Total Annual Compensation$656,880

Stock Options*

All Other Compensation$60,807
Exercisable Options2,031,980
Exercisable Options Value$2,560,526
Unexercisable Options2,153,020
Unexercisable Options Value$1,803,674
Total Value of Options$4,364,200
Total Number of Options4,185,000

Total Compensation*

Total Annual Cash Compensation$1,069,587
Total Short Term Compensation$656,880
Other Long Term Compensation$60,807
Total Calculated Compensation$6,071,003
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:GR €3.54 EUR -0.049

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$884.3K
Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
--
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
$651.2K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$675.0K
Steven A. Victor M.D.Chairman, Chief Executive Officer, President, Principal Accounting Officer, Treasurer and Secretary
IntelliCell BioSciences, Inc.
$275.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.